· Snark Labs · Research
PE-22-28: Mechanism, Evidence, and Dosing Protocols
PE-22-28 is a synthetic analog of spadin that blocks TREK-1 potassium channels — a novel antidepressant mechanism completely distinct from SSRIs, SNRIs, or any approved psychiatric drug. The animal data is promising. The human data does not exist.